Lineage-positive cells were removed using ... To gain insights into FLT3-ITD signaling properties in early hematopoietic progenitor cells, we analyzed STAT5 activation at the CLP and MMP cell ...

First-in-class approach enables the generation of transgene-free hematopoietic stem cells through mechanosensitive PIEZO1 ...

In this single-arm trial, the median overall survival (OS) observed was 4.0 months (95% CI: 2.5-7.2) among all 64 adults in the primary efficacy analysis based on the Kaplan-Meier estimate. The median ...

Detailed price information for Foghorn Therapeutics Inc (FHTX-Q) from The Globe and Mail including charting and trades.

Stem cells can produce any other cell type, it is just a matter of telling them in the right way. From a biological ...

CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Lineage Cell Therapeutics, Inc. (LCTX) on Tuesday reported a loss of $4.1 million in its first quarter. The Carlsbad, California-based company ...

The randomized, open-label, multicenter study is designed to assess whether GPC-100, a small molecule CXCR4 antagonist, can improve CD34+ hematopoietic stem cell mobilization from the bone marrow ...

This valuable study investigates how stochastic and deterministic factors are integrated during cellular decision-making, particularly in situations where cells differentiate into distinct fates ...

A study in the journal Nature explains how age reshapes the blood system. In both humans and mice, a few stem cells, or ...